Renaissance Technologies
BCAB icon

Renaissance Technologies’s BioAtla BCAB Stock Holding History

Renaissance Technologies’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,210
Closed -$82.2K – 3204
2026
Q1 		$82.2K Sell
10,210
-3,934
-28% -$46K ﹤0.01% 3056
2025
Q4 		$401K Sell
14,144
-1,869
-12% -$73.3K ﹤0.01% 2660
2025
Q3 		$551K Buy
16,013
+928
+6% +$21.4K ﹤0.01% 2744
2025
Q2 		$299K Buy
15,085
+188
+1% +$3.81K ﹤0.01% 3041
2025
Q1 		$258K Sell
14,897
-1,695
-10% -$36.3K ﹤0.01% 2987
2024
Q4 		$490K Buy
16,592
+6,364
+62% +$534K ﹤0.01% 2854
2024
Q3 		$900K Sell
10,228
-2,282
-18% -$191K ﹤0.01% 2508
2024
Q2 		$857K Sell
12,510
-7,416
-37% -$882K ﹤0.01% 2407
2024
Q1 		$3.43M Buy
19,926
+176
+0.9% +$21.9K 0.01% 1665
2023
Q4 		$2.43M Buy
19,750
+7,246
+58% +$628K ﹤0.01% 1833
2023
Q3 		$1.06M Sell
12,504
-1,245
-9% -$159K ﹤0.01% 2250
2023
Q2 		$2.06M Buy
13,749
+4,577
+50% +$787K ﹤0.01% 1976
2023
Q1 		$1.23M Sell
9,172
-416
-4% -$74.9K ﹤0.01% 2340
2022
Q4 		$3.96M Sell
9,588
-1,724
-15% -$715K 0.01% 1663
2022
Q3 		$4.36M Sell
11,312
-4,296
-28% -$1.41M 0.01% 1521
2022
Q2 		$2.22M Buy
15,608
+4,879
+45% +$776K ﹤0.01% 2108
2022
Q1 		$2.68M Buy
10,729
+9,311
+657% +$3.89M ﹤0.01% 2001
2021
Q4 		$1.39M Buy
+1,418
New +$1.81M ﹤0.01% 2421

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies's BCAB Position: Q2 2026 in Review

Renaissance Technologies sold out of BioAtla (BCAB) in Q2 2026, closing a stake of 10,210 shares — an estimated $82.2K sold.

Renaissance Technologies first reported a position in BCAB in Q4 2021 and held it in 18 quarters. The position peaked at $4.36M in Q3 2022. 21 funds tracked by Wall St. Rank hold BCAB as of Q2 2026.

  • Renaissance Technologies reported no remaining BioAtla position as of Q2 2026 after selling out during the quarter.
  • Renaissance Technologies sold 10,210 BioAtla shares in Q2 2026, an estimated $82.2K.
  • Renaissance Technologies first reported a position in BioAtla in Q4 2021 and held it in 18 quarters.
  • Renaissance Technologies's BioAtla position peaked at $4.36M in Q3 2022.
  • 21 funds tracked by Wall St. Rank held BioAtla as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.